These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7359324)

  • 21. Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles.
    Fernandez-Urrusuno R; Fattal E; Porquet D; Feger J; Couvreur P
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):272-9. PubMed ID: 7871540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
    Maincent P; Le Verge R; Sado P; Couvreur P; Devissaguet JP
    J Pharm Sci; 1986 Oct; 75(10):955-8. PubMed ID: 3795026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo.
    Song S; Suzuki H; Terasaki T; Lemaire M; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Dec; 287(3):963-8. PubMed ID: 9864280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyalkylcyanoacrylates as colloidal drug carriers.
    Couvreur P
    Crit Rev Ther Drug Carrier Syst; 1988; 5(1):1-20. PubMed ID: 3293806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Everted rat intestinal sacs: a new model for the quantitation of P-glycoprotein mediated-efflux of anticancer agents.
    Carreño-Gómez B; Duncan R
    Anticancer Res; 2000; 20(5A):3157-61. PubMed ID: 11062737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin.
    Rabbani-Chadegani A; Keyvani-Ghamsari S; Zarkar N
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Dec; 84(1):62-7. PubMed ID: 21981942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
    Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani.
    Gaspar R; Opperdoes FR; Préat V; Roland M
    Ann Trop Med Parasitol; 1992 Feb; 86(1):41-9. PubMed ID: 1616394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers.
    Zimmer A
    Methods; 1999 Jul; 18(3):286-95, 322. PubMed ID: 10454987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of cyclodextrins in the formulation of polyalkylcyanoacrylate nanoparticles charged with different active ingredients].
    Duchêne D; Ponchel G; Boudad H; da Silveira AM
    Ann Pharm Fr; 2001 Nov; 59(6):384-91. PubMed ID: 11924510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro investigation of ionic polysaccharide microspheres for simultaneous delivery of chemosensitizer and antineoplastic agent to multidrug-resistant cells.
    Liu Z; Wu XY; Bendayan R
    J Pharm Sci; 1999 Apr; 88(4):412-8. PubMed ID: 10187751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new method to isolate polyalkylcyanoacrylate nanoparticle preparations.
    Pinto-Alphandary H; Balland O; Couvreur P
    J Drug Target; 1995; 3(2):167-9. PubMed ID: 7496730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
    Lenaerts V; Couvreur P; Christiaens-Leyh D; Joiris E; Roland M; Rollman B; Speiser P
    Biomaterials; 1984 Mar; 5(2):65-8. PubMed ID: 6722249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
    Andrieux K; Couvreur P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):463-74. PubMed ID: 20049811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adsorption of aclacinomycin A onto polyisobutylcyanoacrylate nanoparticles].
    Jiang X; Liao G
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):163-6. PubMed ID: 7490023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Targeting bone marrow with the help of polyalkylcyanoacrylate nanoparticles].
    Gibaud S; Weingarten C; Andreux JP; Couvreur P
    Ann Pharm Fr; 1999 Jul; 57(4):324-31. PubMed ID: 10472705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of polyalkylcyanoacrylate nanoparticles I: Free nanoparticles.
    Kante B; Couvreur P; Dubois-Krack G; De Meester C; Guiot P; Roland M; Mercier M; Speiser P
    J Pharm Sci; 1982 Jul; 71(7):786-90. PubMed ID: 7120063
    [No Abstract]   [Full Text] [Related]  

  • 39. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier.
    Damgé C; Michel C; Aprahamian M; Couvreur P
    Diabetes; 1988 Feb; 37(2):246-51. PubMed ID: 3292320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.
    Couvreur P; Kante B; Grislain L; Roland M; Speiser P
    J Pharm Sci; 1982 Jul; 71(7):790-2. PubMed ID: 7120064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.